Weixinkang Pharmaceutical

Tibet Weixinkang Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company focused on the development and commercialization of clinical nutritional products and specialty medications. The company specializes in intravenous nutrition, pediatric medicines, and treatments for gastrointestinal disorders, holding a significant market share in China's parenteral nutrition sector. Their core product portfolio includes multi-vitamin injections for adults and children, compound electrolytes, and trace element formulations designed for patients with impaired oral intake. Weixinkang leverages an integrated R&D-to-production model to address unmet needs in surgical recovery, intensive care, and neonatal health. The company is publicly traded on the Shanghai Stock Exchange and continues to expand its presence through improved generic formulations.